UNSPSC 51293200: Antidepressant hydrazines

Antidepressant drugs made from from or based on diazane (N2H4).

UNSPSC 51293200 Antidepressant hydrazines is a Class code that, based on recent state and local solicitations, encompasses broader pharmaceutical procurement activity — specifically generic multi-source pharmaceuticals, over-the-counter products, and opioid antagonists like naloxone procured by health agencies and cooperative purchasing alliances. The code's nominal scope (antidepressant hydrazines) does not align with the actual work being solicited; state and local buyers are pursuing diverse pharmaceutical categories through this classification. Issuing bodies include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). These entities are buying finished pharmaceutical products for distribution through established wholesaler networks or direct delivery to community health facilities, with vendors responsible for compliance with cGMP, DSCSA, FDA requirements, and substantial insurance coverage (commercial general liability typically $5 million per occurrence).

Recent activity spans Florida, Texas, and the MMCAP member states including Minnesota and Oregon. Seminole County issued an IFB (IFB60459723LAS) in June 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a July 26, 2023 response deadline, seeking quarterly deliveries with all shipping included and contract terms of two years plus one optional renewal. The Texas HHS Commission posted an RFI (HHS0017013) in April 2026 to gather market intelligence on direct-to-manufacturer prescription programs outside traditional PBM and GPO channels, signaling early-stage strategic planning rather than immediate procurement. MMCAP issued an RFP (S1070000015802) in January 2026 for generic multi-source pharmaceuticals and OTC products due March 26, 2026, with contract effective July 1, 2026 for two years; evaluation weights 75 percent on price competitiveness, 10 percent on fixed pricing, and 5 percent each on EDI capability, administrative fee compliance, and format requirements, with vendors required to maintain relationships with at least two of three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, Morris & Dickson).